ABSTRACT
Stroke is considered the most prevalent disabling disorder requiring neurorehabilitation. The cost of care is directly dependent on the ability of patients to return home. It is estimated that approximately 60% of stroke survivors are expected to recover independence, and 75% to walk independently (1). Whether or not neurorehabilitation is efficacious is still controversial because of different variables that contribute to stroke outcomes: severity of neurological deficit, comorbidity, and psychosocial factors (2-4). However, outcome measures are becoming more and more important, especially to assess the efficacy of pharmacological interventions and quality of care provided for stroke patients. To meet these needs a growing number of outcome measures are available. To use them to their best effect, it is important to know their strengths and weaknesses.
